 mL/min/1.73m2, these drugs are contraindicated. Therefore, it is advised to consider these drugs
in type 2 diabetes mellitus and peripheral artery disease
with an eGFR > 30 mL/min/1.73m2 after careful review
and possibly adjustment of other blood glucose lowering
medication to prevent hypoglycaemia, but for SGLT-2
inhibitors there are additional caveats.
The S